Last reviewed: June 5, 2026
Last updated: June 5, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide injection has a half-life of roughly seven days, meaning your body eliminates half the active medication by day seven, while effects persist through the week. This one-week dosing schedule—compared to daily oral alternatives—makes weekly injection therapy the backbone of GLP-1 weight management programs. PlexusDx delivers compounded semaglutide from licensed 503A pharmacies, ensuring consistent dosing windows and predictable appetite control.
How Long Does Semaglutide Injection Stay Active?
Semaglutide injection maintains therapeutic levels in your bloodstream for approximately seven days after a subcutaneous injection. This extended duration allows for once-weekly dosing rather than daily pills, reducing the burden of remembering multiple doses throughout the week. Clinical studies show that peak plasma concentrations occur between 24 and 72 hours after injection, which is when you may experience the strongest appetite-suppressing effects.
The medication doesn't leave your system entirely after seven days; instead, residual amounts continue working at lower concentrations. By day fourteen, roughly 94 percent of the dose has been eliminated, but some activity persists until your next weekly injection. This overlap between weeks creates a cumulative effect where consistent weekly dosing builds stable therapeutic levels in your body.
Dosing Schedule and Duration Timeline
PlexusDx semaglutide injection follows a standard weekly schedule, typically administered on the same day each week to maintain consistent blood levels and predictable appetite suppression. Most patients start at a lower dose and gradually increase over four to five weeks, allowing their bodies to adapt while monitoring tolerance. Your dose may need to go up based on your response, but your price won't—PlexusDx keeps compounded semaglutide flat at $149 per month across all dose levels.
Timing your weekly injection at the same hour each week optimizes the medication's effectiveness and simplifies your routine. If you miss a dose, you can still inject within three days of your scheduled day without significantly disrupting your treatment cycle. For patients seeking deeper personalization, PlexusDx offers the Precision Peptide Genetic Test ($99 add-on) to identify how your genetic variants in GLP1R rs6923761 and other peptide pathways influence your response duration and optimal dosing strategy.
Factors That Affect How Long Semaglutide Works
Individual variations in kidney and liver function can slightly alter how quickly your body processes semaglutide, affecting the duration of appetite suppression. Age, body mass index, and baseline metabolic rate all influence how long the medication circulates at effective levels. Patients with preserved kidney function typically experience the full seven-day therapeutic window, while those with moderate renal impairment may clear the drug somewhat faster.
Genetic factors also play a measurable role in treatment response and duration. The Precision Peptide Genetic Test analyzes variants like FTO rs9939609 and MC4R rs17782313, which regulate appetite and satiety pathways, helping predict how long appetite suppression will feel significant for your individual biology. This genetic mapping of 14 pathways and 49 peptides allows PlexusDx to align your injection timing and dose progression with your unique peptide metabolism.
Comparing Semaglutide Injection Duration to Oral Formulations
Oral semaglutide tablets have a much shorter active duration than injections because they are absorbed through the gastrointestinal tract and metabolized more rapidly. Most patients taking oral semaglutide experience appetite suppression for four to six hours after each dose, requiring daily administration to maintain consistent effects. PlexusDx offers oral semaglutide ($249/month) for patients who prefer pills, but the injection form's weekly duration makes it more convenient for busy schedules.
Injectable semaglutide also achieves higher peak concentrations and more sustained blood levels, often producing stronger and more predictable appetite control than oral forms. If weekly dosing aligns better with your lifestyle, PlexusDx compounded semaglutide injection ($149/month) delivers superior duration with no membership fees, insurance required, or flat per-compound pricing changes. Both formulations are HSA/FSA eligible, making them accessible regardless of your insurance status.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Does semaglutide continue working after seven days?
Yes, semaglutide continues to exert effects beyond seven days at lower concentrations, though therapeutic appetite suppression is strongest during the first 3–5 days post-injection. By day seven, your next weekly dose is timed to maintain continuous therapeutic levels.
What happens if I take my semaglutide shot early or late?
Taking your injection up to three days early or late (within a six-day window) minimally disrupts your blood levels and therapeutic effect. Consistency matters most for appetite control, so setting a recurring weekly alarm helps optimize your results.
How much does compounded semaglutide cost per month?
PlexusDx compounded semaglutide injection costs a flat $149 per month, regardless of your dose level, across all three commitment tiers. This pricing model means your dose can increase throughout your titration without any increase to your monthly cost.
Can genetic testing help predict how long semaglutide will work for me?
Yes, the PlexusDx Precision Peptide Genetic Test ($99 add-on) identifies your genetic variants in GLP1R, GIPR, FTO, and MC4R pathways, which influence how your body metabolizes appetite-suppressing peptides and duration of satiety effects.
Is compounded semaglutide the same quality as brand-name Ozempic?
PlexusDx semaglutide comes from licensed 503A compounding pharmacies, which follow FDA oversight and quality standards for compounded injectables. While compounded formulations are not FDA-approved as finished products, they are manufactured under strict pharmaceutical-grade conditions to match therapeutic equivalence.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
How to Reduce GLP-1 Naturally: A Comprehensive Approach
Does It Matter Where You Inject Tirzepatide?